Zkusit zdarma
Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc.

ENTA
Cena:
$ 13.95
+0.12 (0.87%)
Valuace
70
Růst
0
Zdraví
55
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates

18:10 11-05-2026

Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.45 per share versus the Zacks Con...

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026

16:01 11-05-2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals (ENTA) Moves 5.3% Higher: Will This Strength Last?

Enanta Pharmaceuticals (ENTA) Moves 5.3% Higher: Will This Strength Last?

10:06 07-05-2026

Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading ...

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026

7:00 04-05-2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria

7:00 13-04-2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals (NASDAQ:ENTA) Shares Pass Below 200 Day Moving Average – Should You Sell?

Enanta Pharmaceuticals (NASDAQ:ENTA) Shares Pass Below 200 Day Moving Average – Should You Sell?

3:11 03-04-2026

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA - Get Free Report) passed below its 200-day moving averag...

Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)

Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)

7:00 30-03-2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

13:02 12-02-2026

Enanta Pharmaceuticals (ENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimis...

Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting

Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting

7:00 10-02-2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

18:06 09-02-2026

Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.42 per share versus the Zacks Con...

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025

16:01 09-02-2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of “Moderate Buy” by Brokerages

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of “Moderate Buy” by Brokerages

1:41 18-01-2026

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA - Get Free Report) have been given a consensus ...

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

20:25 14-01-2026

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transc...

Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook

Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook

7:00 08-01-2026

WATERTOWN, Mass.--(BUSINESS WIRE)-- #KIT--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-sta...

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

10:21 22-12-2025

Enanta Pharmaceuticals (ENTA) saw its shares surge in the last session with trading volume being hig...

Wall Street Analysts Believe Enanta Pharmaceuticals (ENTA) Could Rally 44.85%: Here's is How to Trade

Wall Street Analysts Believe Enanta Pharmaceuticals (ENTA) Could Rally 44.85%: Here's is How to Trade

10:56 21-11-2025

The consensus price target hints at a 44.9% upside potential for Enanta Pharmaceuticals (ENTA). Whil...

Enanta: Maintaining Buy Rating Based On Zelicapavir Potential In RSV Development

Enanta: Maintaining Buy Rating Based On Zelicapavir Potential In RSV Development

15:01 19-11-2025

Enanta Pharmaceuticals (ENTA) remains a "Buy" due to promising secondary endpoints for zelicapavir i...

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025

16:01 17-11-2025

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences

7:00 04-11-2025

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot...

Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025

Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025

7:00 20-10-2025

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biot...

close

ENANTA PHARMACEUTICALS TO PRESENT PRECLINICAL DATA FOR EDP-978, ITS KIT INHIBITOR IN DEVELOPMENT FOR THE TREATMENT OF TYPE 2 IMMUNE DISEASES, AT THE 2026 AAAAI ANNUAL MEETING

10-02-2026
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FIRST QUARTER ENDED DECEMBER 31, 2025

09-02-2026
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS PROVIDES UPDATE ON ITS RESEARCH AND DEVELOPMENT PROGRAMS AND 2026 OUTLOOK

08-01-2026
WATERTOWN, MASS.--(BUSINESS WIRE)-- #KIT--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STA...
Více zde

ENANTA PHARMACEUTICALS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

05-01-2026
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ: ENTA), A CLINICAL-STAGE BIO...
Více zde

ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FOURTH QUARTER AND YEAR-ENDED SEPTEMBER 30, 2025

17-11-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

04-11-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS PRESENTS NEW DATA FOR ZELICAPAVIR, ITS N-PROTEIN INHIBITOR, AND EDP-323, ITS L-PROTEIN INHIBITOR, BOTH IN DEVELOPMENT FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AT IDWEEK™ 2025

20-10-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO PRESENT DATA FOR ZELICAPAVIR AND EDP-323, TWO CANDIDATES IN DEVELOPMENT FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AT IDWEEK™ 2025

07-10-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES CLOSING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK, INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

02-10-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK

30-09-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

30-09-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS REPORTS POSITIVE TOPLINE RESULTS FROM ITS PHASE 2B STUDY OF ZELICAPAVIR FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) IN HIGH-RISK ADULTS

29-09-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ: ENTA), A CLINICAL-STAGE BIO...
Více zde

ENANTA PHARMACEUTICALS TO PRESENT TOPLINE RESULTS FROM ITS PHASE 2B STUDY EVALUATING ZELICAPAVIR FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) IN HIGH-RISK ADULTS

26-09-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO PARTICIPATE IN SEPTEMBER INVESTOR CONFERENCES

21-08-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS FILES PATENT INFRINGEMENT SUIT AGAINST PFIZER IN THE UNIFIED PATENT COURT OF THE EUROPEAN UNION

20-08-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ: ENTA), A CLINICAL-STAGE BIO...
Více zde

ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL THIRD QUARTER ENDED JUNE 30, 2025

11-08-2025
WATERTOWN, MASS.--(BUSINESS WIRE)-- #KIT--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STA...
Více zde

ENANTA PHARMACEUTICALS TO PARTICIPATE IN THE H.C. WAINWRIGHT & CO. “HCW@HOME” SERIES

05-08-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO PARTICIPATE IN BAIRD'S BIOTECH DISCOVERY SERIES

15-07-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS' PARTNER ABBVIE RECEIVES U.S. FDA APPROVAL OF AN EXPANDED INDICATION FOR MAVYRET® (GLECAPREVIR/PIBRENTASVIR) AS THE FIRST AND ONLY TREATMENT FOR PEOPLE WITH ACUTE HEPATITIS C VIRUS

11-06-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

27-05-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES DATA FROM ITS PHASE 2 STUDY OF ZELICAPAVIR IN CHILDREN WITH RESPIRATORY SYNCYTIAL VIRUS TO BE PRESENTED AT THE 43RD ANNUAL ESPID MEETING

22-05-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES RESPIRATORY SYNCYTIAL VIRUS DATA PRESENTATION AT ESCMID GLOBAL 2025

08-04-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS ANNOUNCES RESPIRATORY SYNCYTIAL VIRUS DATA...
Více zde

ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FIRST QUARTER ENDED DECEMBER 31, 2024

10-02-2025
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO APPEAL RULING RELATED TO ‘953 PATENT INFRINGEMENT LAWSUIT

24-12-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ: ENTA), A CLINICAL-STAGE BIO...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE RESULTS FROM FIRST-IN-PEDIATRICS PHASE 2 STUDY EVALUATING ZELICAPAVIR FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV)

09-12-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS TO PRESENT TOPLINE RESULTS FROM FIRST-IN-PEDIATRICS PHASE 2 STUDY EVALUATING ZELICAPAVIR FOR RESPIRATORY SYNCYTIAL VIRUS (RSV)

06-12-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FOURTH QUARTER AND YEAR-ENDED SEPTEMBER 30, 2024

25-11-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

ENANTA PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE RESULTS FOR EDP-323 IN A PHASE 2A HUMAN CHALLENGE STUDY OF HEALTHY ADULTS INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)

26-09-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE RESULTS FOR EDP...
Více zde

ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL THIRD QUARTER

05-08-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL T...
Více zde

ENANTA PHARMACEUTICALS TO PARTICIPATE AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

29-05-2024
WATERTOWN, MASS.--(BUSINESS WIRE)--ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA), A CLINICAL-STAGE BIOT...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-11 00:00:0010-QStáhnout
2026-02-09 00:00:008-KStáhnout
2025-11-19 00:00:0010-KStáhnout
2025-11-17 00:00:008-KStáhnout
2025-10-01 01:00:008-KStáhnout
2025-10-01 00:00:008-KStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-08-27 01:00:008-KStáhnout
2025-08-27 00:00:008-KStáhnout
2025-08-20 01:00:008-KStáhnout
2025-08-20 00:00:008-KStáhnout
2025-08-13 01:00:0010-QStáhnout
2025-08-13 00:00:0010-QStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 00:00:008-KStáhnout
2025-05-14 01:00:0010-QStáhnout
2025-05-14 00:00:0010-QStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 00:00:008-KStáhnout
2025-03-17 00:00:008-KStáhnout
2025-03-16 23:00:008-KStáhnout
2025-02-12 00:00:0010-QStáhnout
2025-02-11 23:00:0010-QStáhnout
2025-02-10 00:00:008-KStáhnout
2025-02-09 23:00:008-KStáhnout
2024-12-09 00:00:008-KStáhnout
2024-12-08 23:00:008-KStáhnout
2024-11-27 00:00:0010-KStáhnout
2024-11-26 23:00:0010-KStáhnout
2024-11-25 00:00:008-KStáhnout
2024-11-24 23:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 00:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 00:00:008-KStáhnout
2024-03-12 00:00:008-KStáhnout
2024-03-11 23:00:008-KStáhnout
2024-02-08 00:00:0010-QStáhnout
2024-02-07 23:00:0010-QStáhnout
2024-02-07 00:00:008-KStáhnout
2024-02-06 23:00:008-KStáhnout
2023-12-26 00:00:008-KStáhnout
2023-12-25 23:00:008-KStáhnout
2023-11-22 00:00:0010-KStáhnout
2023-11-21 23:00:0010-KStáhnout
2023-11-20 00:00:008-KStáhnout
2023-11-19 23:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 00:00:008-KStáhnout
2023-04-27 01:00:008-KStáhnout
2023-04-27 00:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-03-07 00:00:008-KStáhnout
2023-03-06 23:00:008-KStáhnout
2023-02-08 00:00:0010-QStáhnout
2023-02-07 23:00:0010-QStáhnout
2023-02-07 00:00:008-KStáhnout
2023-02-06 23:00:008-KStáhnout
2022-11-23 00:00:0010-KStáhnout
2022-11-22 23:00:0010-KStáhnout
2022-11-21 00:00:008-KStáhnout
2022-11-20 23:00:008-KStáhnout
2022-08-26 01:00:008-KStáhnout
2022-08-26 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-06-22 01:00:008-KStáhnout
2022-06-22 00:00:008-KStáhnout
2022-05-17 01:00:008-KStáhnout
2022-05-17 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-03-09 00:00:008-KStáhnout
2022-03-08 23:00:008-KStáhnout
2022-03-08 00:00:008-KStáhnout
2022-03-07 23:00:008-KStáhnout
2022-02-10 00:00:0010-QStáhnout
2022-02-09 23:00:0010-QStáhnout
2022-02-08 00:00:008-KStáhnout
2022-02-07 23:00:008-KStáhnout
2021-11-24 00:00:0010-KStáhnout
2021-11-23 23:00:0010-KStáhnout
2021-11-22 00:00:008-KStáhnout
2021-11-21 23:00:008-KStáhnout
2021-08-23 01:00:008-KStáhnout
2021-08-23 00:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 00:00:008-KStáhnout
2021-07-16 01:00:008-KStáhnout
2021-07-16 00:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 00:00:008-KStáhnout
2021-03-05 00:00:008-KStáhnout
2021-03-04 23:00:008-KStáhnout
2021-02-09 00:00:0010-QStáhnout
2021-02-08 23:00:0010-QStáhnout
2021-02-08 00:00:008-KStáhnout
2021-02-07 23:00:008-KStáhnout
2021-02-05 00:00:008-KStáhnout
2021-02-04 23:00:008-KStáhnout
2020-12-04 00:00:008-KStáhnout
2020-12-03 23:00:008-KStáhnout
2020-11-25 00:00:0010-KStáhnout
2020-11-24 23:00:0010-KStáhnout
2020-11-23 00:00:008-KStáhnout
2020-11-22 23:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-08-04 01:00:008-KStáhnout
2020-08-04 00:00:008-KStáhnout
2020-06-30 01:00:008-KStáhnout
2020-06-30 00:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-02-10 00:00:0010-QStáhnout
2020-02-09 23:00:0010-QStáhnout
2020-02-06 00:00:008-KStáhnout
2020-02-05 23:00:008-KStáhnout
2019-11-27 00:00:0010-KStáhnout
2019-11-26 23:00:0010-KStáhnout
2019-11-21 00:00:008-KStáhnout
2019-11-20 23:00:008-KStáhnout
2019-08-09 01:00:0010-QStáhnout
2019-08-09 00:00:0010-QStáhnout
2019-08-06 01:00:008-KStáhnout
2019-08-06 00:00:008-KStáhnout
2019-05-10 01:00:0010-QStáhnout
2019-05-10 00:00:0010-QStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 00:00:008-KStáhnout
2019-03-06 00:00:008-KStáhnout
2019-03-05 23:00:008-KStáhnout
2019-02-08 00:00:0010-QStáhnout
2019-02-07 23:00:0010-QStáhnout
2019-02-06 00:00:008-KStáhnout
2019-02-05 23:00:008-KStáhnout
2018-11-29 00:00:0010-KStáhnout
2018-11-28 23:00:0010-KStáhnout
2018-11-26 00:00:008-KStáhnout
2018-11-25 23:00:008-KStáhnout
2018-08-09 01:00:0010-QStáhnout
2018-08-09 00:00:0010-QStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 00:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 00:00:008-KStáhnout
2018-03-02 00:00:008-KStáhnout
2018-03-01 23:00:008-KStáhnout
2018-02-09 00:00:0010-QStáhnout
2018-02-08 23:00:0010-QStáhnout
2018-02-07 00:00:008-KStáhnout
2018-02-06 23:00:008-KStáhnout
2017-12-11 00:00:0010-KStáhnout
2017-12-10 23:00:0010-KStáhnout
2017-11-20 00:00:008-KStáhnout
2017-11-19 23:00:008-KStáhnout
2017-09-13 01:00:008-KStáhnout
2017-09-13 00:00:008-KStáhnout
2017-08-09 01:00:0010-QStáhnout
2017-08-09 00:00:0010-QStáhnout
2017-08-07 01:00:008-KStáhnout
2017-08-07 00:00:008-KStáhnout
2017-05-10 01:00:0010-QStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-05-08 01:00:008-KStáhnout
2017-05-08 00:00:008-KStáhnout
2017-02-21 00:00:008-KStáhnout
2017-02-20 23:00:008-KStáhnout
2017-02-09 00:00:0010-QStáhnout
2017-02-08 23:00:0010-QStáhnout
2017-02-08 00:00:008-KStáhnout
2017-02-07 23:00:008-KStáhnout
2017-01-06 00:00:008-KStáhnout
2017-01-05 23:00:008-KStáhnout
2016-12-09 00:00:0010-KStáhnout
2016-12-08 23:00:0010-KStáhnout
2016-11-22 00:00:008-KStáhnout
2016-11-21 23:00:008-KStáhnout
2016-11-21 00:00:008-KStáhnout
2016-11-20 23:00:008-KStáhnout
2016-08-09 01:00:0010-QStáhnout
2016-08-09 00:00:0010-QStáhnout
2016-08-08 01:00:008-KStáhnout
2016-08-08 00:00:008-KStáhnout
2016-05-10 01:00:0010-QStáhnout
2016-05-10 00:00:0010-QStáhnout
2016-05-09 01:00:008-KStáhnout
2016-05-09 00:00:008-KStáhnout
2016-02-16 00:00:008-KStáhnout
2016-02-15 23:00:008-KStáhnout
2016-02-09 00:00:0010-QStáhnout
2016-02-08 23:00:0010-QStáhnout
2016-02-08 00:00:008-KStáhnout
2016-02-07 23:00:008-KStáhnout
2015-12-14 00:00:008-KStáhnout
2015-12-13 23:00:008-KStáhnout
2015-12-11 00:00:0010-KStáhnout
2015-12-10 23:00:0010-KStáhnout
2015-11-23 00:00:008-KStáhnout
2015-11-22 23:00:008-KStáhnout
2015-11-20 00:00:008-KStáhnout
2015-11-19 23:00:008-KStáhnout
2015-08-18 01:00:008-KStáhnout
2015-08-18 00:00:008-KStáhnout
2015-08-10 01:00:0010-QStáhnout
2015-08-10 00:00:0010-QStáhnout
2015-08-06 01:00:008-KStáhnout
2015-08-06 00:00:008-KStáhnout
2015-05-08 01:00:0010-QStáhnout
2015-05-08 00:00:0010-QStáhnout
2015-05-07 01:00:008-KStáhnout
2015-05-07 00:00:008-KStáhnout
2015-02-25 00:00:008-KStáhnout
2015-02-24 23:00:008-KStáhnout
2015-02-06 00:00:0010-QStáhnout
2015-02-05 23:00:0010-QStáhnout
2015-02-05 00:00:008-KStáhnout
2015-02-04 23:00:008-KStáhnout
2014-12-22 00:00:008-KStáhnout
2014-12-21 23:00:008-KStáhnout
2014-12-11 00:00:008-KStáhnout
2014-12-11 00:00:0010-KStáhnout
2014-12-10 23:00:008-KStáhnout
2014-12-10 23:00:0010-KStáhnout
2014-11-24 00:00:008-KStáhnout
2014-11-23 23:00:008-KStáhnout
2014-10-21 01:00:008-KStáhnout
2014-10-21 00:00:008-KStáhnout
2014-10-01 01:00:008-KStáhnout
2014-10-01 00:00:008-KStáhnout
2014-08-12 01:00:0010-QStáhnout
2014-08-12 00:00:0010-QStáhnout
2014-08-11 01:00:008-KStáhnout
2014-08-11 00:00:008-KStáhnout
2014-05-12 01:00:008-KStáhnout
2014-05-12 01:00:0010-QStáhnout
2014-05-12 00:00:008-KStáhnout
2014-05-12 00:00:0010-QStáhnout
2014-04-22 01:00:008-KStáhnout
2014-04-22 00:00:008-KStáhnout
2014-03-05 00:00:008-KStáhnout
2014-03-04 23:00:008-KStáhnout
2014-02-13 00:00:008-KStáhnout
2014-02-13 00:00:0010-QStáhnout
2014-02-12 23:00:008-KStáhnout
2014-02-12 23:00:0010-QStáhnout
2014-02-11 00:00:008-KStáhnout
2014-02-10 23:00:008-KStáhnout
2014-02-07 00:00:008-KStáhnout
2014-02-06 23:00:008-KStáhnout
2014-02-04 00:00:008-KStáhnout
2014-02-03 23:00:008-KStáhnout
2014-01-31 00:00:008-KStáhnout
2014-01-30 23:00:008-KStáhnout
2014-01-10 00:00:008-KStáhnout
2014-01-09 23:00:008-KStáhnout
2013-12-18 00:00:0010-KStáhnout
2013-12-17 23:00:0010-KStáhnout
2013-12-10 00:00:008-KStáhnout
2013-12-09 23:00:008-KStáhnout
2013-11-26 00:00:008-KStáhnout
2013-11-25 23:00:008-KStáhnout
2013-11-25 00:00:008-KStáhnout
2013-11-24 23:00:008-KStáhnout
2013-11-18 00:00:008-KStáhnout
2013-11-17 23:00:008-KStáhnout
2013-09-03 01:00:008-KStáhnout
2013-09-03 00:00:008-KStáhnout
2013-08-21 01:00:008-KStáhnout
2013-08-21 00:00:008-KStáhnout
2013-08-12 01:00:008-KStáhnout
2013-08-12 01:00:0010-QStáhnout
2013-08-12 00:00:008-KStáhnout
2013-08-12 00:00:0010-QStáhnout
2013-05-15 01:00:0010-QStáhnout
2013-05-15 00:00:0010-QStáhnout
2013-05-08 01:00:008-KStáhnout
2013-05-08 00:00:008-KStáhnout
2013-03-28 00:00:008-KStáhnout
2013-03-27 23:00:008-KStáhnout
preloader